What is Alphametry?

We are a new platform where the entire chain of research management, from discovery, procurement, organization, evaluation to its granular analyze can be done in one simple app.

The latest MiFID2 regulatory obligations are built-in Alphametry Investor, a complete research management solution for the buy-side.

Is research free on Alphametry?

No. Sponsored research only is publicly available and premium research during trial period for Alphametry Investor's customers. The price of research subscription and services are negotiated directly with providers off-platform. Upon agreement, providers instantly activate the content access through Alphametry.

Alphametry does not intermediate research but payments can be facilitated with commission management partners such as Instinet or ITG, and corresponding analytics consolidated in Alphametry Investor.

What is a note or interaction access?

Our model is usage-based on two metrics tracked in real-time: an unique access of a note or interaction per user, and a note or interaction import.

A user is an individual consumer registered with Alphametry (typically a portfolio manager) and unique means that only the very first access of a note is chargeable. Access is an accessible note that is fully opened —not just the viewing of the title or teaser.

What is a note or interaction import?

Besides consuming research directly from Alphametry providers, buy-side firms can also import notes from their usual providers in order to consolidate and evaluate fully their written research. Imports can be automated.

Thanks to our Outlook plugin, research interactions like analyst calls or meetings are automatically imported into Alphametry Investor. When one interaction is actually confirmed by a buy-side participant or more, it became an import.

What features do I benefit from in Alphametry Investor?

All of them. Our pricing model is usage-based. It includes current and new features to come.

How many users can I set up in Alphametry?

As many as you wish. Our pricing model is usage-based and comes with unlimited logins. 

Research providers

Is Alphametry free?

Partly. Publishing, tags enrichment, text indexing and discovery of premium content —including company and analysts' names, reports’ titles and teasers—, and discovery analytics are free.

Our premium research management solution includes MiFID2-ready trial request, research provision at user-level for prospects and clients, unlimited custom research packages distribution and advanced readership analytics.

How do research providers get paid?

Directly from consumer firms or through commission management partners such as Instinet or ITG.

Alphametry does not intermediate research, hence does not currently support payments.

How does your contributor pricing work?

Our model is usage-based on a single metric tracked in real-time: a user unique note access.

A user is an individual consumer registered with Alphametry (typically a portfolio manager) and unique means that only the very first access of a note is chargeable. Access is an accessible note that is fully opened —not just the viewing of the title or teaser.

Can I control who sees my research?

Yes. Thanks to our premium access control feature, providers can define how many users, for how long, access their content for each of the organizations they have a commercial agreement with, or prospects they have started a trial period with. Trial requests can be accepted or rejected, and monitor in a consolidated dashboard in real-time. 

No print nor download are available in Alphametry.

Can I create different research packages?

Yes. Alphametry Contributor includes the capability to create and distribute to targeted research consumer organizations unlimited notes feeds.


What are the biggest change in terms of research regulation?

Research unbundling is here. After years of debate, there are still differences in local interpretations, for example between France and the UK. US brokers are also in a position where they can not receive direct payment for their research. 

How this affects the longer term development of the market?

Longer term, the research industry will be dramatically affected and essentially driven by two very intimately linked factors – quality and delivery. The rise of niche positioning will fragment research offerings and raise standards overall. All-digital delivery will push research into a new era of big data scalability. Emerging technology advances will make it much easier and faster for asset managers to adapt a growing and more diverse set of sources of research to their investment decision processes. 

What are the areas of potential upside for research providers and consumers?

Separation from execution is creating opportunities for new, smaller and alternative producers. Platforms are paving the way to easier monetization, but more importantly, enabling the collection, analysis and collaborative use of information within buy-side organisations. These new tools are rapidly becoming crucial in the extremely competitive landscape of active asset management. 

Can the buy-side benefit from new market structures and technology?

The balance of power in the buy-side/sell-side relationship has been profoundly changing since the 2008 crisis. Unbundling is just another step in the disintermediation process. This does indeed come at a cost for the buy-side, but also opens doors to greater opportunity. A wider range of research offerings that are easier to access help the buy-side on both the competitive and regulatory compliance fronts. 

How Alphametry offering helps the research industry?

Alphametry’s next-generation research platform where distribution meet consumption. Research providers improve their product delivery thanks to our data-driven design and access granular analytics to understand the reach and usage of their work. The buy-side controls its entire research value chain, and have especially the unprecedented ability to precisely and finely monitor usage and better evaluate research. These are necessary to efficiently manage the budgetary aspect of their allocation and selection.